Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 4Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory 1

Interventions

trametinib 3dabrafenib 3talimogene laherparepvec 2pembrolizumab 2Nivolumab 2Ipilimumab 2ulixertinib 1tebentafusp 1pegilodecakin 1omaveloxolone 1methyl 5-aminolevulinate 1lifileucel 1efineptakin alfa 1cemiplimab 1balstilimab 1avelumab 1aldesleukin 1Rose Bengal 1Melphalan 1HhAntag691 1Cyclophosphamide 1Brentuximab Vedotin 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Rose Bengal × Dermatologic × Clear all
NCT01260779 2016-07-11

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Provectus Pharmaceuticals

No longer available
Dermatologic

Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡